The company said it anticipates rapid growth and intends to move to a new Baltimore facility in 2016.
The convertible note funding is part of a larger Series A round currently underway.
Despite the findings of the Hopkins study, for practical and economic reasons many diagnostic laboratories currently only sequence tumor samples or do not believe the tumor-normal approach is necessary.
N-of-One will provide clinical interpretation services for genomic tests conducted as part of the New England Veterans' Integrated Service Network oncology program
If the regional precision medicine program is successful, the VA might expand it for veterans around the country.
Personal Genome Diagnostics will supply its CancerSelect targeted gene panel to test veterans with newly diagnosed lung cancer.
The company plans to bring both tissue-based and blood-based targeted sequencing tests through FDA clearance.
Human Longevity will provide whole genome sequencing services to PGDx, which in turn will provide its cancer genome sequencing services to PGDx.
NEW YORK (GenomeWeb) – Appistry said today that it has signed a deal to include Personal Genome Diagnostics' CancerSelect panel in the recently released Appistry CloudDx genomics testing service.
NEW YORK (GenomeWeb News) – Cancer genome analysis firm Personal Genome Diagnostics today announced it raised $2.8 million in private funding in its first external financing round.
GenomeWeb reports that Veritas Genetics is suspending its US operations.
A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.
Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.
In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.